These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10571601)

  • 21. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
    Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N; Motola-Kuba M; Candia R; Arrese M; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2014; 13(4):420-8. PubMed ID: 24927613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ondansetron on portal hemodynamics in liver cirrhosis.
    Tripkovic M; Kozjek F; Krizman I; Jereb J; Francetic I; Grabnar I; Mrhar A
    Int J Clin Pharmacol Ther; 2000 Sep; 38(9):436-40. PubMed ID: 11020031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol.
    Iwao T; Oho K; Sakai T; Sato M; Nakano R; Yamayaki M; Toyonaga A; Tanikawa K
    J Hepatol; 1998 May; 28(5):847-55. PubMed ID: 9625321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
    Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
    J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical vs haemodynamic response to drugs in portal hypertension.
    McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
    J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
    Andreu V; Perello A; Moitinho E; Escorsell A; García-Pagán JC; Bosch J; Rodés J
    J Hepatol; 2002 Mar; 36(3):356-61. PubMed ID: 11867179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
    Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol.
    Mies S; Neto OB; Beer A; Baía CE; Alfieri F; Pereira LM; Sette MJ; Raia S
    Dig Dis Sci; 1997 Apr; 42(4):751-61. PubMed ID: 9125644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
    Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
    J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.